HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarci... von Hingorani, Sunil R, Zheng, Lei, Bullock, Andrea J, Seery, Tara E, Harris, William P, Sigal, Darren S, Braiteh, Fadi, Ritch, Paul S, Zalupski, Mark M, Bahary, Nathan, Oberstein, Paul E, Wang-Gillam, Andrea, Wu, Wilson, Chondros, Dimitrios, Jiang, Ping, Khelifa, Sihem, Pu, Jie, Aldrich, Carrie, Hendifar, Andrew E

Volltext

Temozolomide in malignant gliomas: current use and future targets von VILLANO, J. Lee, SEERY, Tara E, BRESSLER, Linda R

Volltext

Temozolomide in malignant gliomas: current use and future targets von Villano, J. Lee, Seery, Tara E., Bressler, Linda R.

Volltext

Phase 2 study of MK‐2206, an allosteric inhibitor of AKT, as second‐line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)... von Ramanathan, Ramesh K., McDonough, Shannon L., Kennecke, Hagen F., Iqbal, Syma, Baranda, Joaquina C., Seery, Tara E., Lim, Howard J., Hezel, Aram F., Vaccaro, Gina M., Blanke, Charles D.

Volltext

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib von Choi, Joon-Il, Imagawa, David K, Bhosale, Priya, Bhargava, Puneet, Tirkes, Temel, Seery, Tara E, Lall, Chandana

Volltext

Role of Primary Tumor Resection Among Chemotherapy-Treated Patients with Synchronous Stage IV Colorectal Cancer: A Survival Analysis von Tsang, Walter Y, Ziogas, Argyrios, Lin, Bruce S., Seery, Tara E., Karnes, William, Stamos, Michael J., Zell, Jason A.

Volltext

Current Options for Third-Line Treatment of Metastatic Colorectal Cancer von Grothey, Axel, Marshall, John L, Seery, Tara E

Volltext

Mortality Risk After Preoperative Versus Postoperative Chemotherapy and Radiotherapy in Lymph Node-Positive Rectal Cancer von Seery, Tara E., Ziogas, Argyrios, Lin, Bruce S., Pan, Chuan-Ju G., Stamos, Michael J., Zell, Jason A.

Volltext

Abstract CT120: Axitinib safety and pharmacokinetics in Child-Pugh A and Child-Pugh B patients with advanced hepatocellular cancer von Kang, Yoon-Koo, Seery, Tara E., Kato, Mina, Chakrabarti, Debasis, Valota, Olga, Chen, Ying, Tang, Jie, Pithavala, Yazdi K., Kudo, Masatoshi

Volltext

The Prevalence of Second Malignancies and Autoimmune Diseases in Patients with Lymphoproliferative Disorders von Seery, Tara E., Sycheva, Tatyana, Oo, Thein H.

Volltext

Liver Imaging : Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib von Joon Il Choi, David K Imagawa, Priya Bhosale, Puneet Bhargava, Temel Tirkes, Tara E Seery, Chandana Lall

Volltext

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313 von Ramanathan, Ramesh K, McDonough, Shannon L, Philip, Philip A, Hingorani, Sunil R, Lacy, Jill, Kortmansky, Jeremy S, Thumar, Jaykumar, Chiorean, E Gabriela, Shields, Anthony F, Behl, Deepti, Mehan, Paul T, Gaur, Rakesh, Seery, Tara, Guthrie, Katherine A, Hochster, Howard S

Volltext

Abstract CT066: Global phase 3, randomized, double-blind, placebo-controlled study evaluating PEGylated recombinant human hyaluronidase PH20 (PEGPH20) plus nab-paclitaxel and gemci... von Zheng, Lei, Hendifar, Andrew E., Reni, Michele, Harris, William P., Ducreux, Michel, Bullock, Andrea J., Corrie, Pippa G., Seery, Tara, Chondros, Dimitrios, Cutsem, Eric Van

Volltext

A phase IB/II randomized study of mFOLFIRINOX (mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status metastatic p... von Ramanathan, Ramesh K., McDonough, Shannon, Philip, Philip Agop, Hingorani, Sunil R., Lacy, Jill, Kortmansky, Jeremy S., Thumar, Jaykumar Ranchodbhai, Chiorean, E. Gabriela, Shields, Anthony Frank, Behl, Deepti, Mehan, Paul Tracy, Gaur, Rakesh, Seery, Tara Elisabeth, Guthrie, Katherine, Hochster, Howard S.

Volltext